Tyrosine Kinase
Tyrosine Kinase(酪氨酸激酶)
- Bcr-Abl(73)
- Ack1(3)
- Axl(6)
- ALK(64)
- BMX Kinase(3)
- Broad Spectrum Protein Kinase Inhibitor(10)
- c-FMS(42)
- c-Kit(58)
- c-MET(99)
- c-RET(7)
- CSF-1R(3)
- DDR1/DDR2 Receptor(1)
- EGFR(278)
- EphB4(1)
- FAK(39)
- FGFR(104)
- FLT3(97)
- HER2(15)
- IGF1R(34)
- Insulin Receptor(46)
- IRAK(32)
- ITK(10)
- Lck(1)
- LRRK2(25)
- PDGFR(113)
- PTKs/RTKs(10)
- Pyk2(8)
- ROR(41)
- Spleen Tyrosine Kinase (Syk)(33)
- Src(108)
- Tie-2 (4)
- Trk(43)
- VEGFR(200)
- Kinase
- Discoidin Domain Receptor(16)
- DYRK(35)
- Ephrin Receptor(13)
- RET(30)
- ROS(14)
- TAM Receptor(33)
- IGFBR(1)
- Others(55)
Tyrosine Kinase 相关产品(1402)
- GC32733Pyrotinib (SHR-1258)CAS: 1269662-73-8纯度: >99.50%
Pyrotinib (SHR-1258) (SHR-1258) 是一种有效的选择性 EGFR/HER2 双重抑制剂,IC50 分别为 13 和 38 nM。
- GC32760Dovitinib lactate (CHIR-258 lactate)CAS: 692737-80-7纯度: >99.50%
Dovitinib lactate (CHIR-258 lactate)是一种高效,具有口服活性和安全药代动力学特性的小分子多激酶抑制剂,作用于FLT3、KIT和FGFR等靶点,IC 50 值分别为1、2和8-9nM。
- GC32819Mirk-IN-1 (Dyrk1B/A-IN-1)CAS: 1386979-55-0纯度: >99.50%
Mirk-IN-1 (Dyrk1B/A-IN-1) 是一种有效的 Dyrk1B(Mirk kianse) 和 Dyrk1A 抑制剂,IC50 分别为 68±48 nM 和 22±8 nM。
- GC32836Naquotinib mesylate (ASP8273)CAS: 1448237-05-5纯度: >98.00%
An irreversible inhibitor of mutant EGFRs
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC32625 | KDR-in-4 | 408502-06-7 | - | |
KDR-in-4 (KDR-in-4) 是一种有效的激酶插入结构域受体 (KDR/VEGFR2) 抑制剂,IC50 为 7 nM。 | ||||
| GC32703 | Asciminib (ABL001) | 1492952-76-7 | >99.50% | |
An allosteric inhibitor of Abl1 | ||||
| GC32713 | Cintirorgon (LYC-55716) | 2055536-64-4 | >98.00% | |
A ROR? agonist | ||||
| GC32726 | Tucatinib (Irbinitinib) | 937263-43-9 | >99.00% | |
An inhibitor of HER2 | ||||
| GC32733 | Pyrotinib (SHR-1258) | 1269662-73-8 | >99.50% | |
Pyrotinib (SHR-1258) (SHR-1258) 是一种有效的选择性 EGFR/HER2 双重抑制剂,IC50 分别为 13 和 38 nM。 | ||||
| GC32748 | CA-4948 | 1801343-74-7 | >99.50% | |
An IRAK-4 inhibitor | ||||
| GC32752 | TAS6417 | 1661854-97-2 | >98.50% | |
TAS6417 (CLN-081, TPC-064) is a novel EGFR inhibitor that targets EGFR exon 20 insertion mutations while sparing wild-type (WT) EGFR. IC50 values ranges from 1.1 ± 0.1 to 8.0 ± 1.1 nmol/L. | ||||
| GC32760 | Dovitinib lactate (CHIR-258 lactate) | 692737-80-7 | >99.50% | |
Dovitinib lactate (CHIR-258 lactate)是一种高效,具有口服活性和安全药代动力学特性的小分子多激酶抑制剂,作用于FLT3、KIT和FGFR等靶点,IC 50 值分别为1、2和8-9nM。 | ||||
| GC32769 | MRX-2843 (UNC2371) | 1429882-07-4 | >98.00% | |
A Mer and FLT3 inhibitor | ||||
| GC32797 | AD80 | 1384071-99-1 | >99.50% | |
AD80, a multikinase inhibitor, shows strong activity against human RET (c-RET), BRAF, S6K, and SRC but were much less active than either AD57 or AD58 against mTOR. The IC50 value for RET is 4 nM. | ||||
| GC32802 | PRN1371 | 1802929-43-6 | >99.50% | |
An irreversible pan-FGFR inhibitor | ||||
| GC32805 | Sulfatinib (HMPL-012) | 1308672-74-3 | >98.00% | |
A multi-kinase inhibitor | ||||
| GC32808 | Selitrectinib (LOXO-195) | 2097002-61-2 | >99.00% | |
A Trk kinase inhibitor | ||||
| GC32819 | Mirk-IN-1 (Dyrk1B/A-IN-1) | 1386979-55-0 | >99.50% | |
Mirk-IN-1 (Dyrk1B/A-IN-1) 是一种有效的 Dyrk1B(Mirk kianse) 和 Dyrk1A 抑制剂,IC50 分别为 68±48 nM 和 22±8 nM。 | ||||
| GC32825 | eCF506 | 1914078-41-3 | >99.00% | |
An inhibitor of Src kinases | ||||
| GC32835 | PP58 | 212391-58-7 | >99.00% | |
PP58是吡啶[2,3-d]嘧啶化合物,抑制PDGFR,FGFR和Src家族活性的IC50值在纳摩尔级。 | ||||
| GC32836 | Naquotinib mesylate (ASP8273) | 1448237-05-5 | >98.00% | |
An irreversible inhibitor of mutant EGFRs | ||||
| GC32864 | Ensartinib hydrochloride (X-396 hydrochloride) | 2137030-98-7 | >99.00% | |
An ALK inhibitor | ||||
| GC32867 | Flumatinib (HHGV678) | 895519-90-1 | >98.00% | |
A Bcr-Abl inhibitor | ||||
| GC32875 | AZM475271 (M475271) | 476159-98-5 | >99.50% | |
An inhibitor of c-Src kinase | ||||
| GC32915 | Pemigatinib | 1513857-77-6 | >98.00% | |
An FGFR inhibitor | ||||
| GC32927 | PF-06459988 | 1428774-45-1 | >99.00% | |
PF-06459988是T790M-ContainingEGFRMutants不可逆性抑制剂。 | ||||
| GC32963 | hVEGF-IN-1 | 1637443-98-1 | >98.50% | |
hVEGF-IN-1是一种喹唑啉衍生物(IRES-A:K d = 0.928μM)。 | ||||
| GC32968 | FLT3-IN-1 | 1472797-69-5 | - | |
FF-10101 is a novel irreversible FLT3 inhibitor with ic50 of 0.20 nM and 0.16 nM for FLT3 (WT) and FLT3(D835Y), respectively. | ||||
